Bristol Myers lines up many launches for India with 'AI' speed

Bristol Myers Squibb sees India as a major growth driver. The company is investing heavily in AI to speed up drug launches and improve doctor engagement. New medicines for heart conditions and cancer are coming to India. This strategic move aims to boost sales and prepare for patent expirations. India is becoming a hub for AI innovation for the company.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/t7Dn5Xl
via IFTTT